Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$13.1MFederal grants as PI19 awards
6Patents grantedLatest Jun 30, 2026
47Papers1,007 citations
Federal awards and patents by year
AwardsPatents
19 awards · $13.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 17, 2026 | NIH | SBIR Phase II Noninvasive assessment of neurovascular coupling for early diagnosis of cognitive impairment | $948K | VASOPTIC MEDICAL, INC. |
| Aug 19, 2026 | NIH | SBIR Phase II Imaging of episcleral venous blood flow for assessment of micro-invasive glaucoma surgery | $1000K | VASOPTIC MEDICAL, INC. |
| Sep 18, 2025 | NIH | STTR Phase I Imaging of Neurovascular Response for Assessment of Alzheimer's Disease | $500K | VASOPTIC MEDICAL, INC. |
| Sep 18, 2023 | NIH | SBIR Phase II Ocular Blood Flow Imaging for Glaucoma Assessment | $246K | VASOPTIC MEDICAL, INC. |
| May 30, 2023 | NIH | SBIR Phase II Ocular Blood Flow Imaging for Glaucoma Assessment | $875K | VASOPTIC MEDICAL, INC. |
| Mar 30, 2023 | NIH | SBIR Phase II Dye-free, on-demand visualization of blood flow during cerebrovascular surgery | $883K | VASOPTIC MEDICAL, INC. |
| May 3, 2022 | NIH | SBIR Phase II Ocular Blood Flow Imaging for Glaucoma Assessment | $675K | VASOPTIC MEDICAL, INC. |
| Apr 1, 2022 | NIH | SBIR Phase II Dye-free, on-demand visualization of blood flow during cerebrovascular surgery | $1.6M | VASOPTIC MEDICAL, INC. |
| Sep 1, 2021 | NIH | SBIR Phase I Assessment of episcleral vasculature for glaucoma management | $257K | VASOPTIC MEDICAL, INC. |
| Sep 1, 2020 | NIH | SBIR Phase I Blood Flow Imaging for Minimally Invasive Surgeryhttps://apps.era.nih.gov/grantfolder/viewInternalGF.era?applId=10008550 | $256K | VASOPTIC MEDICAL, INC. |
| May 18, 2020 | NIH | SBIR Phase I Development of Flow Based Biomarkers for Retinopathy of Prematurity - Supplemental Aim | $96K | VASOPTIC MEDICAL, INC. |
| Sep 1, 2019 | NIH | SBIR Phase I Development of Flow Based Biomarkers for Retinopathy of Prematurity - Supplemental Aim | $389K | VASOPTIC MEDICAL, INC. |
| Aug 28, 2019 | NIH | SBIR Phase I Development of Flow Based Biomarkers for Retinopathy of Prematurity | $293K | VASOPTIC MEDICAL, INC. |
| Aug 29, 2018 | NIH | SBIR Phase II Real Time Noninvasive Monitoring of Blood Flow During Surgery | $742K | VASOPTIC MEDICAL, INC. |
| Jul 20, 2018 | NIH | SBIR Phase II Laser Speckle Imaging Chip for Telehealth Applications | $746K | VASOPTIC MEDICAL, INC. |
| Sep 20, 2017 | NIH | SBIR Phase II Real Time Noninvasive Monitoring of Blood Flow During Surgery | $1.5M | VASOPTIC MEDICAL, INC. |
| Sep 15, 2017 | NIH | SBIR Phase II Laser Speckle Imaging Chip for Telehealth Applications | $1.5M | VASOPTIC MEDICAL, INC. |
| Jun 30, 2015 | NIH | SBIR Phase I Laser Speckle Imaging Chip for Telehealth Applications | $340K | VASOPTIC MEDICAL, INC. |
| May 10, 2015 | NIH | SBIR Phase I Real time and noninvasive monitoring of blood flow during surgery | $249K | VASOPTIC MEDICAL, INC. |
7 patents as inventor
- US 10722116VASOPTIC MEDICAL, INC.Jul 28, 2020
- US 11020015VASOPTIC MEDICAL, INC.Jun 1, 2021
- US 11666238VASOPTIC MEDICAL, INC.Jun 6, 2023
- US 11766172VASOPTIC MEDICAL, INC.Sep 26, 2023
- US 12667254VASOPTIC MEDICAL, INC.Jun 30, 2026
- US 9492083VASOPTIC MEDICAL, INC.Nov 15, 2016
- US VASOPTIC MEDICAL, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#35
Awards as PI#32
Patents#42
Companies
- VASOPTIC MEDICAL, INC.Leads (SEC Form D) · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.